诺和诺德 NVO 深沪

交易中 10-07 11:14:08 美东时间

118.39

+3.270

+2.84%

华盛通

立即下载

最高118.5493
今开117.11
成交量 170.69万股
最低 117.08
昨收 115.12
总市值 5269.54亿
52周最高 147.7877
市盈率 ^静 43.83
换手率 0.04%
52周最低 89.4742
委比 8.11%
总股本 44.51亿
历史最高 147.7877
量比 1.36
振幅 1.28%
历史最低 3.5732
每手 1
风险率 15.81%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

诺和诺德(NVO)涨超2% 拟投资约1.58亿美元改造位于巴西的一家工厂

金吾资讯

17分钟前
新型减肥药(GLP-1)或导致肌肉流失速度快于普通人群医药巨头警告：可能“弊大于利”

金吾资讯

今天 20:21
美股前瞻 | 三大股指期货齐跌高盛预计标普500有望再涨10%

10月7日(周一)美股盘前，美股三大股指期货齐跌。

今天 19:46
Regeneron sees IPR&D impact of about $0.43/share on Q3 income

Regeneron Pharmaceuticals (NASDAQ:REGN) expects its third results to include an acquired in-process research and development charge of about $56M on a pre-tax basis. The charge relates to development ...

今天 19:21
医药巨头警告：若不解决这个问题，减肥神药可能“弊大于利”

临床数据显示，注射礼来公司的药物后，其中有25%的体重减轻来自于肌肉等瘦体重（即去脂体重，=体重-脂肪重量）的减少，而注射诺和诺德的药物后则有40%的体重减轻是...

今天 13:05
欧股一线｜中东局势升级点燃欧股避险情绪，预期欧洲央行10月继续降息

21世纪经济报道见习记者赖镇桃广州报道上周，中东动荡局势再升级，资本市场不安情绪随之上升。欧股普遍由历史高点回落。上周，欧洲STOXX 600指数累跌1...

今天 11:38
四环医药（00460）：医药行业中成功转型的企业代表

低估且成长性十足，加上大手笔回购，在资本市场火热的背景下，四环医药的估值有望重塑~

今天 08:55
Can Novo, Lilly take credit for U.S. obesity rate decline?

A recent CDC report indicated that the U.S. obesity rates may have dropped after over a decade-long rise last year, a finding likely to highlight the role played by the new weight loss drugs from Novo...

10-06 01:45
诺和诺德公司承诺投资1.582亿美元于巴西胰岛素工厂

丹麦制药公司诺和诺德公司宣布投资1.582亿美元升级其位于巴西东南部米纳斯吉拉斯州蒙特斯克拉罗斯的胰岛素生产设施，这是该公司制造能力的重大扩张。根据公司周五发布...

10-05 03:42
UnitedHealthcare is latest to sue Medicare over Star Ratings

UnitedHealthcare (NYSE:UNH) has become the latest to legally challenge the Medicare Advantage Star Ratings system, which allows health insurers to receive bonus payments from the government. The lawsu...

10-05 03:37

派息除权日	每股总股息	派息日期
2024-08-16	0.37	2024-08-26
2024-03-22	0.66	2024-04-02
2023-08-18	0.63	2023-08-29
2023-03-24	0.85	2023-04-04
2022-08-12	0.41	2022-08-23
2022-03-25	0.74	2022-04-05
2021-08-16	0.39	2021-08-25
2021-03-26	0.68	2021-04-07
2020-08-14	0.37	2020-08-25
2020-03-27	0.56	2020-04-07
2019-08-16	0.32	2019-08-27
2019-03-22	0.56	2019-04-02
2018-08-17	0.33	2018-08-28
2018-03-23	0.58	2018-04-03
2017-08-17	0.34	2017-08-29
2017-03-23	0.48	2017-04-04
2016-08-11	0.33	2016-08-23
2016-03-18	0.70	2016-03-30
2015-03-19	0.53	2015-03-31
2014-03-21	0.61	2014-04-02
2013-03-21	2.26	2013-04-02
2012-03-22	1.83	2012-04-03
2011-03-24	1.36	2011-04-05
2010-03-25	0.98	2010-04-07
2009-03-19	0.78	2009-03-31
2008-03-13	0.68	2008-03-25
2007-03-08	1.24	2007-03-20
2006-03-09	0.69	2006-03-21
2005-03-10	0.62	2005-03-22
2004-03-17	0.52	2004-03-29
2003-03-26	0.38	2003-04-07
2002-03-13	0.28	2002-03-25
2001-03-21	0.57	2001-04-02
2000-03-24	0.44	2000-04-06
1999-03-25	0.42	1999-04-06
1998-03-27	0.31	1998-04-08
1997-04-25	0.21	1997-05-07
1996-05-01	0.18	1996-05-14
1995-04-24	0.19	1995-05-16
1994-04-26	0.13	1994-05-18
1993-04-22	0.54	1993-05-13
1992-04-28	0.54	1992-05-20
1991-04-19	0.51	1991-05-10
1990-04-23	0.53	1990-05-15
1989-04-21	0.46	1989-05-12
1988-04-21	0.52	1988-05-12
1987-04-20	0.41	1987-05-11
1986-04-21	0.34	1986-05-12
1985-04-19	0.26	1985-05-10
1984-04-13	0.28	1984-05-04
1983-04-13	0.27	1983-05-05
1982-04-23	0.26	1982-05-20

公司名称	诺和诺德
行业分类	制药
业务描述	Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsv \|rd, Denmark.

诺和诺德 NVO 深 沪

118.39

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

诺和诺德 NVO 深沪